Abstract
The measurement of CNS effects is particularly relevant for a new drug, not only when this drug is supposed to exert a psychotropic effect, but also for drugs acting on other systems for which possible side-effects or adverse reactions at the level of the CNS need to be investigated and assessed at the earliest stage of development.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
References
Aitken, R. C. B. (1969). Measurement of feelings using visual analogue scales. Proc. Roy. Soc. Med., 62, 989
Barlow, S. M., Knight, A. F. and Sullivan, F. M. (1979). Plasma corticosterone responses to stress following chronic oral administration of diazepam in the rat. J. Pharm. Pharmacol., 31, 23–6
Barrett, J. E. and Di Mascio, A. (1966). Comparative effects on anxiety of the ‘minor tranquilizers’ in ‘high’ and ‘low’ anxious student volunteers. Dis. Nerv. Syst., 27, 483–6
Beaumont, P. J. V., Corker, C. S., Friesen, H. G., Gelder, M. G., Harris, G. W., Kolakowska, T. and Mandelbrote, B. M. (1974). The effects of phenothiazines on endocrine function. I. Patients with inappropriate lactation and amenorrhoea. II. Effects in men and post-menopausal women. Br. J. Psychiat., 124, 413–30
Beck, A. T. (1985). Theoretical perspectives on clinical anxiety. In Turman, A. H. and Maser, J. D. (Eds.), Anxiety and the Anxiety Disorders. Erlbaum Associates, London, pp. 183–96
Biehl, B. (1974). The effects of two tranquillizers on driving performance as measured in the normal driving task. Proceedings 18th Congress of International Association of Applied Psychology, Montreal
Birren, J. E., Woods, A. M. and Williams, M. V. (1984). Behavioural slowing with age. Causes, organisations and consequences. In Pook, L. W. (Ed.), Ageing in the 1980s: Psychological Issues. APA, Washington, D.C.
Buchsbaum, M. S., Rigal, F., Coppola, R., Cappelletti, J., King, C. and Johnson, J. (1982). A new system for gray-level surface distribution maps of electrical activity. Electroencephalogr. Clin. Neurophysiol., 53, 237–42
Buhler, R. A. (1955). Flicker fusion threshold and anxiety level. Psychol. Abstr., 29, 701
Claridge, G. S. (1967). Personality and Arousal. Pergamon Press, Oxford
Claridge, G. S. (1970). Drugs and Human Behaviour. Allen Lane, London
Creese, I., Burt, D. R. and Snyder, S. H. (1976). Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science, N.Y., 192, 481–3
Crown, S. and Crisp, A. H. (1970). Manual of the Middlesex Hospital Questionnaire. Psychological Test Publications, Barnstable
De Wied, C. (1967). Chlorpromazine and endocrine function. Pharm. Rev., 19, 251–98
Di Mascio, A., Meyer, R. E. and Stifler, L. (1968). Effects of imipramine on individuals varying in level of depression. Am. J. Psychiat., 124, 55
Dublinsky, J. and Barlow, J. S. (1980). A single dot-density topogram for EEG. Electroencephalogr. Clin. Neurophysiol., 48, 473–7
Duffy, F. H., Burchfield, J. L. and Lombroso, C. T. (1979). Brain electrical activity mapping (BEAM): a method for extending the clinical utility of EEG and evoked potential data. Am. Neurol., 5, 309–21
Etevenon, P., Peron-Magnan, P. and Boulenger, J. P. (1986). EEG cartography profile of caffeine in normals. Clin. Neuropharm., 9 (S4), 538–40
Etevenon, P., Peron-Magnan, P., Verdeaux, G., Gaches, J. and Denicker, P. (1983). Electroencephalographie quantitative en neurologie et psychiatric Poster 422, 473A. Colloque Génie Biologique et Médical, Toulouse, p. 43
Eysenck, H. J. (1957). Drugs and personality. Theory and methodology. J. Ment. Sci., 103, 119–31
Eysenck, H. J. (1963). Experiments with Drugs. Pergamon Press, Oxford
Eysenck, H. J. (1972). Handbook of Abnormal Psychology. Pitman Medical, London
Eysenck, H. J. and Eysenck, S. B. G. (1964). Eysenck Personality Inventory. University of London Press, London
Fargus, P. C. G. and Hindmarch, I. (1974). A 1,4-benzodiazepine, temazepam: effect on reaction time related to car driving. IRCS Med. Sci., 2, 1173
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G. and Munoz, R. (1972). Diagnostic criteria for use in psychiatric research. Arch. Gen. Psychiatr., 29, 57–67
Fink, M. (1969). Ann. Rev. Pharmacol., 9, 241
Fuxe, K. and Hokfelt, T. (1969). Catecholamines in the hypothalamus and the pituitary gland. In Ganong, W. F. and Martin, L. (Eds.), Frontiers in Neuroendocrinology. Oxford University Press, New York
Goldstone, S. (1955). Critical flicker fusion measurements and anxiety level. J. Exp. Psychol., 49, 200–2
Gudgeon, A. C. and Hindmarch, I. (1983). Midazolam: Effects on psychomotor performance and subjective aspects of sleep and sedation in normal volunteers. Br. J. Clin. Pharm., 16, 121S–126S
Herman, W. M. (1982). In Herman, W. M. (Ed.), Electroencephalography in Drug Research. Gustav Fischer, Stuttgart, New York, p. 249
Hindmarch, I. (1975). A 1,4-benzodiazepine, temazepam: its effect on psychological aspects of sleep and behaviour. Arzneimittel forschung, 25, 1836–9
Hindmarch, I. (1979a). A preliminary study of the effects of repeated doses of clobazam on aspects of performance, arousal and behaviour in a group of anxiety rated volunteers. Eur. J. Clin. Pharm., 16, 17–21
Hindmarch, I. (1979b). Some aspects of the effects of clobazam on human performance. Br. J. Clin. Pharm., 7, 77S–82S
Hindmarch, I. (1979c). Effects of hypnotic and sleep inducing drugs on objective assessments of human psychomotor performance and subjective appraisals of sleep and early morning behaviour. Br. J. Clin. Pharm., 8, 43S–46S
Hindmarch, I. (1980). Psychomotor function and psychoactive drugs. Br. J. Clin. Pharm., 10, 1189–209
Hindmarch, I. (1981). Measuring the effects of psychoactive drugs on higher brain function. In Burrows, G. D. and Werry, J. S. (Eds.), Advances in Human Psychopharmacology II. JAI Press, pp. 79–106
Hindmarch, I. (1982). Antidepressant drugs and performance. Bri. J. Clin. Pract., 19, 73–7
Hindmarch, I. (1983). Measuring the side-effects of psychoactive drugs: a pharmacodynamic profile of alprazolam. Alcohol and Alcoholism, 18, 361–7
Hindmarch, I. (1984a). The Leeds Sleep Evaluation Questionnaire (LSEQ) as a measure of the subjective response to nocturnal treatment with benzodiazepines. In Burrows, G. D., Norman, T. R. and Maguire, K. P. (Eds.), Biological Psychiatry: Recent Studies. J. Libbey, London, pp. 228–39
Hindmarch, I. (1984b). Psychological performance models as indicators of the effects of hypnotic drugs on sleep. In Hindmarch, I., Ott, H. and Roth, T. (Eds.), Sleep, Benzodiazepines and Performance. Springer-Verlag, Heidelberg, pp. 58–69
Hindmarch, I. (1985). Anxiety, performance and anti-anxiety drugs. Br. J. Clin. Pract., 39, 53–8
Hindmarch, I. (1986). The effects of psychoactive drugs on car handling and related psychomotor ability: a review. In O’Hanlon, J. F. and de Gier, J. F. (Eds.), Drugs and Driving. Taylor and Francis, London, pp. 71–82
Hindmarch, I. (1987). Three antidepressants (amitriptyline, dothiepin, fluoxetine), with and without alcohol, compared with placebo on tests of psychomotor ability related to car driving. Hum. Psychopharm., 2, 177–83
Hindmarch, I. and Gudgeon, A. C. (1982). Loprazolam (HR158) and flurazepam with ethanol compared on tests of psychomotor ability. Eur. J. Clin. Pharm., 23, 509–12
Hindmarch, I., Parrott, A. C. and Stonier, P. D. (1980). The effects of nomifensine and HOE8476 on car driving and related psychomotor performance. In Stonier, P. D. and Jenner, F. A. (Eds.), Nomifensine. Royal Society of Medicine International Congress and Symposium Series No. 25, London, pp. 47–54
Hollister, L. E. (1985). In Smith, D. E. and Wesson, D. R. (Eds.), The Benzodiazepines, Current Standards for Medical Practice. MTP Press, Lancaster, p. 87
Itil, T. M. (1974). In Itil, T. M. (Ed.), Modern Problems of Pharmacopsychiatry, Vol. 8: Psychotropic Drugs and Human EEG, Karger, Basle, p. 43
Itil, T. M. (1982). In Herman, W. M. (Ed.), EEG in Drug Research. Gustav Fischer, Stuttgart, New York, p. 131
Jones, O. (1958). Relationship between visual and auditory discrimination and anxiety levels. J. Gen. Psychol., 59, 111–18
Kleinberg, D. L., Wharton, R. N. and Frantz, A. G. (1971). Rapid release of prolactin in normal adults following chlorpromazine stimulation. 53rd Programme of Endocrine Society Meetings, San Francisco, p. 126
Krugman, H. (1947). Flicker fusion frequency as a function of anxiety reaction: an exploratory study. Psychosomat. Med., 4, 269–72
Lehmann, D. (1971). Multichannel topography of human alpha EEG fields. Electroencephalogr. Clin. Neurophysiol., 31, 439–49
Leygonie, F., Rethone, A., Yuleyatak, F. and Yuceyatiak, A. (1975). Anxiolitique nouveau, le clobazam, action sur le sommeil de nuit et le niveau de performance au réveil. Gaz. Med. France, 82, 1303
McNeil, T. H. and Sladek, J. R. (1978). Fluorescence-immunocytochemistry: simultaneous localization of catecholamines and gonadotrophin-releasing hormone. Science, N.Y., 200, 72–4
Malpas, A., Legg, N. J. and Scott, D. F. (1974). Effects of hypnotics on anxious patients. Br. J. Clin. Psychiat., 124, 482–4
Martin, J. B. (1973). Neural regulation of growth hormone secretion. New Engl. J. Med., 288, 1384–93
Muller, E. E., Nistico, G. and Scapagnini, E. (1977). Neurotransmitters and Anterior Pituitary Function. Academic Press, New York.
Nowlis, V. (1965). Research with the mood adjective check-list. In Tomkins, S. and Izard, C. (Eds.), Affect, Cognition and Personality. Springer-Verlag, New York, p. 352
Paykel, E. S. and Prusoff, B. A. (1973). Response set and observer set in the assessment of depressed patients. Psychol. Med., 3, 209–16
Petsche, H. (1973). EEG topography. In Remond, A. (Ed.), Handbook of Electroencephalography and Clinical Neurophysiology. Elsevier, Amsterdam
Poldinger, W. and Wider, F. (1983). In Langer, G. and Heiman, H. (Eds.), Psychopharmarka, Grundlagen und Therapie. Springer-Verlag, Vienna, p. 447
Saletu, B. (1976). Bibliotheca Psychiatrica, No. 155. Karger, Basle.
Saletu, B., Grünberger, J., Berner, P. and Koeppen, D. (1985). In Hindmarch, I., Stonier, P. D. and Trimble, M. R. (Eds.), Clobazam: Human Psychopharmacology and Clinical Applications, International Congress and Symposium Series, No. 74. Royal Society of Medicine, London, p. 23
Saletu, B., Grünberger, J., Linzmayer, L. and Flener, R. (1981). Agressologie, 22, 5
Saletu, B., Grünberger, J., Volavka, J. and Berner, P. (1979). Arzneim. Forsch. Drug Res., 29, 700
Saletu, B., Küfferle, B., Grünberger, J. and Anderer, P. (1986). Pharmacopsychiatrie, 19, 36–52
Sebban, C. L., Debouzy, C. L. and Berthaux, P. (1984). EEG quantifié et cartographie numérisée. In Lassen, N. A. and Cahn, J. (Eds.), Maladies et Médicaments. Libbey, London, pp. 176–81
Siegfried, K. (1987). Towards a clinical classification of antidepressant profiles. In Hindmarch, I. and Stonier, P. D. (Eds.), Human Psychopharmacology, Vol. II. Wiley, Chichester
Siegfried, K. and O’Connolly, M. (1986). Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression. Int. Clin. Psychopharm., 1, 221–30
Siegfried, K., Jansen, W. and Pahnke, K. (1984). Cognitive dysfunction in depression. Drug. Dev. Res., 4, 533–53
Spielberger, C. D., Goruch, R. L. and Lushene, R. E. (1968). Manual for State-Trait Anxiety Inventory. Florida State University, Tallahassee
Spielberger, C. D., Gorsuch, R. L. and Lushene, R. E. (1970). Manual for the State-Trait Anxiety Inventory. Consulting Psychologist Press, Palo Alto
Sylvalahti, E. and Kanto, J. (1975). Serum growth hormone, serum immunoreactive insulin and blood responses to oral and intravenous diazepam in man. Int. J. Clin. Pharm., 12, 74–82
Taeuber, K., Zapf, R., Rupp, W. and Badian, M. (1979). Pharmacodynamic comparison of the acute effects of nomifensine, amphetamine and placebo in healthy volunteers. Int. J. Clin. Pharm. Biopharm., 17 (1), 32–7
Tansella, M., Zimmermann-Tansella, C. and Lader, M. (1974). The residual effects of N-desmethyldiazapam in patients. Psychopharmacologica (Berlin), 38, 81–90
Walter, G. and Shipton, H. (1951). A new toposcopic display system. Electroencephalogr. Clin. Neurophysiol., 3, 281–92
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1990 The editors and contributors
About this chapter
Cite this chapter
Musch, B., Hindmarch, I., Saletu, B. (1990). Measurement of CNS Effects. In: O’Grady, J., Linet, O.I. (eds) Early Phase Drug Evaluation in Man. Palgrave, London. https://doi.org/10.1007/978-1-349-10705-6_30
Download citation
DOI: https://doi.org/10.1007/978-1-349-10705-6_30
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-10707-0
Online ISBN: 978-1-349-10705-6
eBook Packages: EngineeringEngineering (R0)